Related Experiment Video
Updated: May 20, 2026
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
Nanotechnology applications for glioblastoma
Edjah K Nduom1, Alexandros Bouras, Milota Kaluzova
1Department of Neurosurgery, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
Abstract:
Glioblastoma remains one of the most difficult cancers to treat and represents the most common primary malignancy of the brain. Although conventional treatments have found modest success in reducing the initial tumor burden, infiltrating cancer cells beyond the main mass are responsible for tumor recurrence and ultimate patient demise. Targeting residual infiltrating cancer cells requires the development of new treatment strategies. The emerging field of cancer nanotechnology holds promise in the use of multifunctional nanoparticles for imaging and targeted therapy of glioblastoma. This article examines the current state of nanotechnology in the treatment of glioblastoma and directions of further study.
Insights
Glioblastoma, a challenging brain cancer, often recurs due to infiltrating cells. Cancer nanotechnology offers new hope for targeted therapies and imaging to combat these persistent cancer cells.
Area of Science:
- Oncology
- Biomedical Engineering
- Nanotechnology
Background:
- Glioblastoma is the most common and difficult-to-treat primary brain malignancy.
- Conventional treatments show limited success against infiltrating cancer cells, leading to recurrence and mortality.
- Targeting residual disease is crucial for improving glioblastoma patient outcomes.
Purpose of the Study:
- To review the current applications of nanotechnology in glioblastoma treatment.
- To explore the potential of multifunctional nanoparticles for glioblastoma therapy and imaging.
- To identify future research directions in nanomedicine for glioblastoma.
Main Methods:
- Review of current literature on nanotechnology in glioblastoma research.
- Analysis of nanoparticle-based strategies for glioblastoma imaging and targeted therapy.
- Discussion of challenges and future prospects in the field.
Main Results:
- Nanoparticles show promise for enhanced glioblastoma imaging.
- Targeted drug delivery systems using nanoparticles can improve therapeutic efficacy.
- Multifunctional nanoparticles offer combined diagnostic and therapeutic capabilities.
Conclusions:
- Nanotechnology presents a promising avenue for overcoming glioblastoma treatment challenges.
- Further research is needed to translate nanotechnological advancements into clinical practice.
- Targeted nanoparticle-based therapies hold potential for improved glioblastoma management.
